Alexander C. Pherson practices in the area of corporate law. Mr. Pherson has represented Fortune 500 companies and investment banks in a variety of capital markets transactions and general corporate matters. His experience includes public and private offerings of equity and debt, initial public offerings and M&A transactions.
Mr. Pherson is a 2014 graduate of Stanford Law School and a summa cum laude graduate of UCLA, where he was elected to Phi Beta Kappa. .
Admissions
- New York
Education
- Stanford Law School, J.D., 2014
- Stanford Journal of Law, Business and Finance - University of California, Los Angeles, B.A., summa cum laude, 2010
- Phi Beta Kappa
Experience
- Duane Morris LLP
- Senior Associate, 2025-present
- Associate, 2020-2024 - Merrill Lynch, Pierce, Fenner & Smith, Inc.
- Financial Advisor, Private Wealth Management, 2016-2020 - Skadden Arps Slate Meagher & Flom LLP
- Law Clerk, 2014-2015
Representative Matters
Represented Jefferies LLC in a $75 million at-the-market (ATM) offering for OS Therapies Incorporated (Nasdaq: OSTX), a clinical-stage cancer immunotherapy company focused on neoplasms (cancers) and related solid tumors, with a primary emphasis on osteosarcoma and other HER2‑positive and targeted solid tumors.
Represented Cantor Fitzgerald & Co. in a $100 million at-the-market (ATM) offering for CapsoVision, Inc (Nasdaq: CV), a Silicon Valley global medical device innovator specializing in diagnostic imaging of the gastrointestinal system.
Represented Jefferies LLC as sales agent in connection with an “at the market” offering by Cognition Therapeutics, Inc. of $75 million of common stock.
Represented Lucid Capital Markets, LLC as sales agent in connection with an “at the market” offering by MedicNova, Inc. of $50 million of common stock.
Represented B. Riley Securities, Inc. and BTIG, LLC as sales agents in connection with an “at the market” offering by Hyperfine, Inc. of $50 million of Class A common stock.



